Nanobiotix

YTD

ALL

Why Robinhood?

You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!

About NBTX

Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.

CEO

Laurent Lévy

CEOLaurent Lévy

Employees

108

Employees108

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

2003

Founded2003

Employees

108

Employees108

NBTX Key Statistics

Market cap

185.62M

Market cap185.62M

Price-Earnings ratio

-4.81

Price-Earnings ratio-4.81

Dividend yield

—

Dividend yield—

Average volume

14.46K

Average volume14.46K

High today

$3.95

High today$3.95

Low today

$3.71

Low today$3.71

Open price

$3.95

Open price$3.95

Volume

3.92K

Volume3.92K

52 Week high

$7.29

52 Week high$7.29

52 Week low

$2.76

52 Week low$2.76

NBTX News

TipRanks 6d

Nanobiotix Discloses Managerial Transactions in Compliance with EU Regulations

Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...

Analyst ratings

90%

of 10 ratings

Buy

90%

Hold

10%

Sell